Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Hugo Fuentes

5PUBLICATIONS
60CO-AUTHORS
Midwifery not elsewhere classifiedEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersAboriginal and Torres Strait Islander midwifery and paediatrics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

Sort by Publication Date:
|Nov 24, 2025
Influence of HER2 Changes on Survival Outcomes After Neoadjuvant Chemotherapy in Peruvian Patients With Triple-Negative Breast Cancer.

Zaida Morante, Yomali Ferreyra, Iris Otoya

|Dec 03, 2024
Evaluation of Multiple Breast Cancer Polygenic Risk Score Panels in Women of Latin American Heritage.

Xiaosong Huang, Paul C Lott, Donglei Hu

|Nov 07, 2024
Impact on Survival with Immunotherapy and Evaluation of Biomarkers in Peruvian Patients with Advanced Melanoma.

Guillermo Valencia, Katia Roque, Patricia Rioja

|Jun 02, 2022
Association between Ancestry-Specific 6q25 Variants and Breast Cancer Subtypes in Peruvian Women.

Valentina A Zavala, Sandro Casavilca-Zambrano, Jeannie Navarro-Vásquez

|Feb 10, 2021
COVID-19 in cancer patients: a systematic review.

Carlos A Castañeda, Miluska Castillo, José Luis Rojas-Vilca

Pageof 1

Frequent Collaborators

4 joint publications

Guillermo Valencia

3 joint publications

Zaida Morante

3 joint publications

Henry L Gómez

3 joint publications

Silvia P Neciosup

3 joint publications

Carlos Castañeda

3 joint publications

Tatiana Vidaurre

2 joint publications

Valentina A Zavala

2 joint publications

Monica Calderón

2 joint publications

Julio E Abugattas

2 joint publications

Donglei Hu

Frequent Collaborators

4 joint publications

Guillermo Valencia

3 joint publications

Zaida Morante

3 joint publications

Henry L Gómez

3 joint publications

Silvia P Neciosup

Top Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

7.5K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

223
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

4.8K
See more related videos

Top Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

7.5K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

223
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

4.8K
See more related videos